Advertisement

SN Applied Sciences

, 1:102 | Cite as

Physical synthesis of iron oxide nanoparticles and their biological activity in vivo

  • Yurii A. Kurapov
  • Elena M. Vazhnichaya
  • Stanislav E. Litvin
  • Sergey M. Romanenko
  • Gennadii G. Didikin
  • Tatiana A. Devyatkina
  • Yevhen V. Mokliak
  • Elena I. Oranskaya
Research Article
  • 106 Downloads
Part of the following topical collections:
  1. 4. Materials (general)

Abstract

The physical synthesis of iron oxide nanoparticles obtained from the vapor phase using the electron beam physical vapor deposition method is considered. The results of studying the structure of porous condensates of iron—sodium chloride compound, chemical and phase compositions, as well as nanoparticles size are presented. With a rapid removal from vacuum, iron nanoparticles are oxidized in the air to magnetite. In the initial state, they have significant sorption capacity with respect to oxygen and moisture, therefore, with further heating in the air, the porous condensate mass decreases up to the temperature 650 °C, primarily due to the desorption of physically sorbed moisture. Physically adsorbed oxygen participates in oxidation of Fe3O4–Fe2O3 in the range of 380–650 °C. An increase in condensation temperature is accompanied by an increase of nanoparticle size, as a result of which the total surface area of nanoparticles is significantly reduced, and, consequently, their sorption capacity is decreased. Even without stabilization, such nanoparticles studied as ex tempore prepared aqueous dispersion have characteristic anti-anemic effect in the laboratory animals that can be used in medicine.

Keywords

EB-PVD Iron oxide nanoparticles Sorption Phase composition Colloid systems Anti-anemic effect 

Abbreviations

DLS

Dynamic light scattering

DTA

Differential thermal analysis

EB-PVD

Electron beam physical vapor deposition

EDS

Energy-dispersive X-ray spectroscopy

Fe3O4

Magnetite, iron(II, III) oxide

Fe2O3

Hematite, iron(III) oxide

γ-Fe2O3

Maghemite, iron(III) oxide

Hb

Hemoglobin

Hct

Hematocrit

m/m0

Relative change of mass of TGA

MCH

Mean corpuscular hemoglobin

MCHC

Mean corpuscular hemoglobin concentration

MCV

Mean corpuscular volume

NaCl

Sodium chloride

NPs

Nanoparticles

p

P-value, used in statistical hypothesis testing

RBC

Red blood cells count

RDW

Width of erythrocytes distribution curve

Rt

Reticulocytes

SEM

Scanning electron microscope

SPIONs

Superparamagnetic iron oxide nanoparticles

T

Temperature

TEM

Transmission electron microscopy

TGA

Thermogravimetric analyzer

Tm

Melting temperature

TS

Substrate temperature

XRD

X-ray diffraction

1 Introduction

The most studied are nanoparticles (NPs) of iron (Fe) oxides–magnetite (Fe3O4) and maghemite (γ-Fe2O3) which are applied in electronics and medicine [1, 2, 3]. The greatest number of works is devoted to the investigation of magnetite NPs of up to 20 nm size which are in superparamagnetic state at room temperature [4, 5]. They are characterized by practically zero residual magnetization that is especially important for medical and biological applications, for example, at transport of drugs through small-diameter blood vessels when particles aggregation is highly undesirable [6].

Multifunctional Fe5C2 NPs exhibit high functional properties in magnetic resonance imaging and photothermal therapy due to their unique core/shell structure with a magnetic core and carbon shell [7]. In [8] synthesized monodisperse Au–Fe2C Janus NPs, which are multifunctional entities for cancer theranostics and showed a significant photothermal effect with 30.2% calculated photothermal transduction efficiency under 808 nm laser irradiation in vitro.

In recent years many works have been devoted to studying core–shell superparamagnetic iron oxide nanoparticle (SPIONs) clusters of about 80 nm size [9, 10]. The authors have investigated the magnetic properties of such a cluster of 10 nm maghemite NPs in amorphous 15 nm thick silicon dioxide shell. It turned out that along with superparamagnetic properties the cluster registers high magnetic moment which is especially important for control by an external magnetic field. Magnetic N-enriched Fe3C/graphitic carbon instead of Pt is also very interesting as an electrocatalyst for the oxygen reduction reaction. It has higher selective operational properties, than commercial Pt/C catalysts in 0.10% KOH solution. The materials exhibit excellent magnetic properties and oxygen reduction reaction activities [11].

Many works are devoted to development of new methods for obtaining and stabilizing metal NPs. Chemical methods of particle synthesis are the leading techniques. Among them liquid-phase chemical condensation method proposed by Elmore is the most common [12]. In this method, the nucleation and growth of particles occurs in the volume or on the surfaces of different nature, shape and sizes that come into contact with the liquid phase [13, 14, 15]. Sol–gel combustion synthesis to produce SPIONs is also notable [16, 17]. It allowed producing NPs with high magnetization and magnetic moment.

The first mention of producing magnetic NPs by physical method (molecular beam method) was made in references [18, 19]. It is based on physical processes of evaporation or sputtering of substances with subsequent deposition of the vapor phase in vacuum, atmosphere of inert or active gases. In this case, radiation, electron beam, laser, and ion-plasma heat sources are used for evaporation and sputtering respectively. Methods for obtaining magnetic NPs and their practical applications are described in the relevant reviews, for example [20, 21].

The method of electron beam evaporation of various substances in vacuum with subsequent condensation of vapor flows, which has been applied at deposition of functional and structural coatings with micro- and nanoscale structure, is also used for synthesis of metal NPs [22, 23, 24, 25, 26]. This method, in addition to high productivity, is also notable for its versatility at selection of various inorganic and organic matrices for the conservation of metal NPs and their oxides. The choice of sodium chloride (NaCl) as a matrix was justified by the fact that this material, when condensed in the temperature range T < 0.3 Tm (Tm is melting temperature), is characterized by open porous structure [27]. Condensing in vacuum in the open pores of this matrix, iron NPs freely oxidize to magnetite in the air. Moreover, NaCl is widely used in medicine as an ingredient of many drugs due to its biological compatibility with living tissues and good solubility in water.

As was noted, biology and medicine are one of the main directions of practical application of magnetite NPs [28, 29]. This is due to magnetic properties and the presence of iron in their composition. Therefore, such NPs have anti-anemic effect due to the replenishment of total iron pool in the body, ability to influence the relaxation time of surrounding protons that improves visualization of certain structures in magnetic resonance imaging, hyperthermic action, as well as the transport effect, consisting in medicinal drugs delivery to target cells by active targeting [30, 31, 32, 33].

Medical use of magnetite NPs requires their stabilization in liquid medium that causes some problems because of the fact that stabilizing substances are capable of modifying the pharmacokinetics of iron oxide NPs and their interaction with the cells [34, 35, 36]. According to this point of view, magnetite NPs, which were deposited in porous, easily soluble and biocompatible matrix, are of considerable practical interest.

The aim of presented research was to synthesize superparamagnetic iron oxide NPs by simultaneous evaporation of iron and sodium chloride and to investigate the effects of iron concentration and condensation temperature on the sorption properties, size and phase composition of these NPs, as well as to study the biological activity of such particles at anemia caused by acute blood loss.

2 Methods

Synthesis of NPs was carried out by condensation of mixed molecular flows of iron and salt in vacuum electron beam installation [37]. An iron ingot was placed into a water-cooled crucible of 50 mm diameter, and pressed cylinder of NaCl was placed in the adjacent crucible. Vacuum of (1.3–2.6) × 10−2 Pa was created in the chamber. Surfaces of the ingot and crucible were heated by electron beam guns up to melting. As a result, a mixed vapour flow of iron and NaCl was formed. It was condensed on a water-cooled substrate, where the temperature was maintained at 40–50 °C. After air intake and complete depressurization of the chamber, the condensate was stripped from the substrate and NPs were examined both in dry powder and in the colloidal solution.

The microstructure and content of elements in the condensate were investigated by scanning electron microscopes VEGA 3 (Tescan, Czech Republic) and CamScan (Cambridge CamScan SEM) with the INCA-200 Energy X-ray imager (Oxford Inca Energy 200 EDS system). Investigation of the particles morphology and phase composition was carried out by transmission electron microscopy (TEM) method using HITACHI H-800 microscope (Hitachi, Japan) at the accelerating voltage of 100 kV. X-ray diffraction (XRD) was studied by DRON-UM1 diffractometer with cobalt (CoKα) radiation and graphite monochromator in reflected beam with the angle range of 10–85 degrees. The average crystallite size was estimated by the Scherrer equation. Semi-quantitative phase analysis was performed using Match! program. The processes of iron oxidation in the salt matrix in air were studied by increasing the temperature to 650 °C at a rate of 10 °C/min using a thermogravimetric analyzer TGA-7 (Perkin Elmer, USA). The size of NPs in the colloidal system was determined by the method of dynamic light scattering (DLS) [38, 39] in Zeta Sizer-3000 laser correlation spectrometer (Malvern, UK).

Condensate with magnetite NPs was dissolved in deionized water at a ratio of 1 mg/1 ml and was studied for stability and hydrodynamic particle size using the DLS method, as described above.

Obtained magnetite NPs were used in the experiments on laboratory animals aimed to determine their biological activity. These experiments were performed on 28 abino male Wistar rats (Rattus norvegicus) with body weight 183–221 g. The rats were randomized, labeled, divided into groups and kept in the standard conditions. The experiments were approved by Commission on Bioethics of Higher State Educational Establishment of Ukraine “Ukrainian Medical Stomatological Academy”. Acute blood loss was simulated by puncture of the heart and removal of 25% of circulating blood volume under the ether anesthesia (3–4 ml/kg of body weight) at the surgical stage [40].

Magnetite NPs deposited in NaCl matrix were used for pharmacological correction of this experimental pathology. They were dispersed ex tempore in the water for injections and administered to the rats intraperitoneally in a dose of 25 mg/kg body weight (6.75 mg Fe/kg) immediately after the blood loss. Blood samples were obtained from the heart of animals under the ether anesthesia 3 and 72 h (h) after the blood loss. Hematological parameters were studied: red blood cells count (RBC), hematocrit (Hct), hemoglobin, (Hb), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), as well as the width of erythrocytes distribution curve (RDW). These indices were examined using hematology analyzer MicroCC-20Plus Vet (High Technology Inc., USA) programmed for blood parameters of albino rats [41]. Reticulocytes (Rt) content was determined using supravital staining with methylene blue during which ribonucleic acid-containing structures appear as granular mesh substance [42]. Painted smears were examined by microscope AmScope T490B-10MT (United Scope LLC, USA) with × 100 lens. Digital findings were statistically processed by standard software package Statistica for Windows 8.0. The mean M, and its standard error m were calculated, and the significance of differences between groups was evaluated using one-way ANOVA analysis with post hoc test Fisher LSD.

3 Results and discussion

The appearance (Fig. 1a) and the surface of obtained Fe-NaCl condensates (Fig. 1b) corresponded to the first zone of low-temperature formation of the nanocrystalline structure [43]. Studies of the macrostructure and content of elements on transverse cleavage of porous Fe-NaCl condensate showed the presence of large amount of oxygen (O) adsorbed by NPs from the air after depressurization of vacuum chamber (Fig. 2, Table 1).
Fig. 1

3D image (a) and surface view (b) of the initial condensate 29 wt% Fe + NaCl obtained by the EB-PVD method at substrate temperature of 40 °C

Fig. 2

Microstructure of the transverse cleavage of the initial condensate (29 wt% Fe + NaCl) obtained by the EB-PVD method at substrate temperature of 40 °C (see Table 1)

Table 1

Elemental composition of transverse cleavage of porous condensate 29 wt% Fe + NaCl, obtained at substrate temperature of 40 °C (see Fig. 2)

Spectrum

wt%

Fe

O

Na

Cl

Spectrum 1

28.6

23.3

19.8

28.3

Spectrum 2

29.1

20.1

19.7

31.1

Spectrum 3

34.8

22.4

17.2

25.6

Spectrum 4

29.0

25.0

19.4

26.6

X-ray phase analysis (Fig. 3a) showed that iron particles in the salt matrix are conserved in two forms: α-Fe and Fe3O4. When the particles are removed from the matrix by salt dissolving in the water, oxidation of pure iron to Fe3O4 and FeOOH oxide-hydroxide takes place (Fig. 3b, Table 2). Before dissolving in water and preparing colloidal solutions, the condensate was ground into a powder to the micron size. Figure 4 shows the granulometric analysis of the resulting powder after many hours of condensate grinding in the agate mortar.
Fig. 3

Diffraction patterns of condensate samples (29 wt% Fe + NaCl) initially (a) and after NaCl washing out (b)

Table 2

Phase composition of the initial condensate 29 wt% Fe + NaCl and after washing with NaCl

Sample

Phase composition

Mean crystallites size (nm)

Phase content (wt%)

Condensate

NaCl JCPDS # 75-306

20

89

α-Fe JCPDS #87-721

20

2

Fe3O4 JCPDS # 88-315

11

9

Condensate washed out from NaCl

Fe3O4 JCPDS # 88-315

10

84

γ-FeOOH JCPDS # 73-2326

8

9

α-FeOOH JCPDS # 81-462

8

7

Fig. 4

The microstructure (a), granules size distribution (b) and volumetric distribution (c) of the particle size in the powder after the grinding of condensate (29 wt% Fe + NaCl) processed by Statgraphics program

TEM of thin cleavages of the condensate revealed the presence of nanoscale substance with advantageous phase composition corresponding to magnetite (Fe3O4). Consequently, when the condensate is extracted from the vacuum into the air, oxygen and moisture of the air freely penetrate and actively interact with developed open surface of iron NPs interspersed in the micro- and nanoscale pores of salt matrix porous structure [27]. When the condensate is quickly removed from vacuum, iron oxide is formed with the release of heat that is confirmed by heating of the condensate separated from the substrate and placed on paper.

Moreover, iron oxide NPs can additionally adsorb physically bound oxygen and moisture to their surface [22]. Taking into account that high adsorption capacity for oxygen is inherent in greater degree to NPs of small size, it can properly affect the study of oxygen content in the condensate with different amounts of iron. Indeed, the ratio of oxygen atomic percentage to the iron atomic percentage depends on the amount of iron, decreases with increase of its content in the condensate and exceeds this value for stoichiometric composition of Fe3O4, equal to 1.33 (Fig. 5, 40 °C curve); and this ratio approaches the stoichiometric one only at about 30 at. % content of iron in the condensate, when the probability of collision of NPs in the mixed vapor flow and during condensation on the substrate is high, leading to some increase in NPs size (Fig. 5, curve 40 °C).
Fig. 5

The ratio of O/Fe in Fe-NaCl condensates obtained at 40 °C and 400 °C depending on the Fe content

This is another indication of the high adsorption capacity of small NPs [13]. One of the main reasons for the change in physical and chemical properties of small particles at reduction of their size, is an increase in the relative fraction of surface atoms which are under other conditions (coordination number, symmetry of local environment, etc.) than the atoms inside the bulk phase. Particle size reduction leads to the increase in the role of surface energy.

However, the condensation temperature has a greater influence on NPs size (Fig. 6). TEM study of particles suspension obtained by condensate dissolving in the aqueous medium revealed the presence of a nanosized substance (Fig. 7a, c, e). The average particle size increases from 3–4 nm up to 15–20 nm as the substrate temperature rises from 20 to 200 °C (Fig. 6). As the particle size grows, the diffraction rings become clear (Fig. 7b, d, e). The phase composition of the particles corresponds to Fe3O4.
Fig. 6

Change in the average particle size of Fe3O4 in Fe-NaCl condensates as a function of substrate temperature TS. 1—TEM study, 2—XRD

Fig. 7

Microstructure (a, c, e) and X-ray diffraction patterns (b, d, f) of Fe3O4 nanoparticles in aqueous colloids of Fe-NaCl condensates as a function of substrate temperature TS: a, b—40 °C; c, d—100 °C; e, f—220 °C

As the temperature of substrate rises, the size of NPs increases, resulting in significant reduction of NPs total surface area that leads to decrease in the ratio of oxygen atomic percentage to the atomic percentage of iron depending on the amount of iron (Fig. 5, 400 °C curve).

The kinetics of relative change in the mass of Fe-NaCl porous condensate heated to 650 °C and cooled in the air, studied by thermogravimetric analysis (TGA), allows us considering these sorption processes in greater detail. As the temperature rises, the mass of Fe-NaCl porous condensate decreases up to the temperature of 650 °C (Fig. 8, curve 2), whereas the kinetics of relative change in the mass of porous NaCl (no Fe) condensate heated to 650 °C and cooled in the air shows (Fig. 8, curve 1) practically no mass change connected with moisture adsorption.
Fig. 8

Kinetics of the relative change in the mass of condensates NaCl (1) and 29 wt% Fe + NaCl (2) with the differential curve (3) for cyclic heating/cooling in the air

The decrease in mass may be due to the competitive nature of adsorption from the air of different gases having different adsorption times [44, 45, 46] and/or large range of binding energies of water molecules to oxides surface [47, 48]. For example, water molecules have adsorption time of at least an order of magnitude greater than that of the main components of the air—oxygen and nitrogen. This means that penetration of water molecules into the condensate to nanoscale particles lags behind in time by an order of magnitude relative to the main components of the air [44]. Thus, at the first moment of condensate contact with air, oxygen of the air is consumed to form iron oxide with high heat release. In their turn, the iron oxide NPs can additionally adsorb oxygen, nitrogen and moisture onto their surfaces. During the lagging of water molecules, the vacancies on the adsorbent surface are occupied by nitrogen and oxygen molecules, but after the arrival of additional water molecules they are also displaced due to the longer adsorption time of the water. Since the molecular weight of water is almost half that of nitrogen and oxygen, and the areas occupied by molecules are comparable, it is logical to expect a decrease in the total mass of adsorbates [44].

Consequently, at the first stage (Fig. 8), when the porous condensate is heated to the temperature of 200 °C, desorption of physically sorbed water occurs. On the Differential Thermal Analysis (DTA) curve, this process corresponds to the observed endoeffect with a peak at 100–120 °C (Fig. 8, curve 3). Then, in the range of 200–650 °C, there is a further change of mass due to removal of chemically bound water (crystallization moisture) and other adsorbates from the structure of Fe-NaCl condensate. Simultaneously, in the range of 380–650 °C, oxidation [22] of Fe3O4 to Fe2O3 takes place due to the remaining fraction of oxygen physically adsorbed by Fe3O4 NPs.

The resulting condensate of Fe3O4 NPs was dissolved in water. The sample contained 1 mg of NPs condensate in 1 ml of bidistilled water, was transparent and of a brownish color. Within 3–5 min after shaking, it formed a dark brown sediment. When studying the particle size distribution in the polymodal approximation, two fractions were determined in the sample. The first one was formed by particles of 13–120 nm size with a maximum at 23 nm. Their amount was 99.9%, and the mass fraction was equal to 46% of all detected NPs. The second fraction contained particles ranging in size from 209 to 3300 nm with a maximum at 209 nm [27]. The number of such particles was 0.1%, and their mass fraction was 54%. So, aqueous dispersion of magnetite NPs after preparation contained nanosized particles in a predominating amount and could be administered to the laboratory animals as nanofluid.

Condensate of magnetite NPs obtained by electron beam physical vapor deposition (EB-PVD) was tested for its biological activity. When studying the biological activity of above described NPs, acute blood loss without the administration of nanofluid served as control pathology. In this control group 3 h after the removal of blood, RBC decreased by 18% (p < 0.001), Hb diminished by 40% (p < 0.001), and Hct decreased by 24% (p < 0.001), as compared to intact animals (Table 3). These changes were accompanied by significant decrease in the mean volume of red blood cells (MCV index) (p < 0.05) without any changes of RDW. The MCH and MCHC indices which characterize the saturation of erythrocytes with hemoglobin decreased by 27% and 21%, respectively (p < 0.001), as compared to those of intact rats. Such hematological changes are typical to early period of acute blood loss and testify the development of hypochromic anemic condition. In this period, magnetite NPs use increased RBC by 9% (p < 0.05) as compared to control pathology (see Table 3). The level of Hb also increased by 25% (p < 0.005), and Hct—by 13% (p < 0.05) in comparison to those without NPs administration. These changes occurred against the background of the growth of erythrocyte index MCH (p < 0.05) and the tendency to MCHC increase (p < 0.1) in the absence of significant changes in MCV and RDW.
Table 3

Effect of magnetite nanoparticles (6.75 mg Fe/kg) deposited in NaCl crystals on hematological parameters in acute blood loss (M ± m)

Parameters

Groups of animals

Intact (n = 8)

Acute blood loss + solvent

3 h (n = 5)

Acute blood loss + magnetite nanoparticles

3 h (n = 5)

Acute blood loss + solvent

72 h (n = 5)

Acute blood loss + magnetite nanoparticles

72 h (n = 5)

RBC (× 1012/L)

7.79 ± 0.20

6.39 ± 0.13*

6.98 ± 0.12*†

5.71 ± 0.12*

6.42 ± 0.16*†

Hb (g/L)

136.6 ± 3.7

81.6 ± 4.1*

102.4 ± 3.1*†

91.0 ± 1.3*

105.0 ± 3.0*†

Hct (units)

0.42 ± 0.02

0.32 ± 0.01*

0.36 ± 0.01*†

0.32 ± 0.01*

0.37 ± 0.01*†

MCV (μm3)

54.3 ± 1.2

50.0 ± 1.0*

52.8 ± 1.6

56.9 ± 0.3

57.3 ± 1.4

MCH (pg)

17.55 ± 0.51

12.88 ± 0.46*

14.80 ± 0.46*†

15.84 ± 0.23*

16.30 ± 0.30

MCHC (g/dL)

324.1 ± 8.8

255.4 ± 4.41*

281.4 ± 7.1*

281.6 ± 3.5*

285.8 ± 2.2*

RDW (%)

11.08 ± 0.35

11.06 ± 0.52

10.56 ± 0.32

10.46 ± 0.13

10.88 ± 0.69

Rt (‰)

62.3 ± 5.9

42.2 ± 3.9*

82.2 ± 6.2*†

107.0 ± 2.0*

139.8 ± 7.4*†

*p < 0.05 as compared to Intact animals; p < 0.05 as compared to blood loss with solvent (control); n number of animals in the group

72 h after the blood removal without correction, significant hematological changes persisted, namely: a decrease in RBC (p < 0.001), lowering in Hb (p < 0.001), and diminishing of Hct (p < 0.001) as compared to intact animals, that was similar to the previous observation period (see Table 3). There was a decrease in MCH (p < 0.02) and MCHC (p < 0.005) with no changes in other erythrocyte indices.

Corrective influence of NPs in this observation period was manifested by the increase in RBC by 12% (p < 0.02), Hb—by 15% (p < 0.02) and Hct—by 16% (p < 0.05) as compared to similar parameters at acute blood loss without magnetite NPs administration (see Table 3), even though all the mentioned parameters stayed lower than in the intact animals. In this case, erythrocyte indices were the same as for control pathology.

Bone marrow regenerative reaction was evaluated by the count of Rt in the blood (see Table 3). Intact rats had Rt content 62.3 ± 5.9‰. 3 h after the blood loss, this parameter was significantly lower than that in the intact animals (p < 0.02). Such development of processes can be explained by both the loss of these cells with the removed blood and accelerated transformation of circulating Rt to mature red blood cells under the conditions of intense erythropoiesis provoked by blood loss. 72 h after the removal of blood, Rt content was increased by 1.7 times (p < 0.001) as compared to that in the intact animals, which is a natural reaction to compensate blood loss.

After the administration of magnetite NPs and investigation at 3 h from the removal of blood, Rt content increased and was 1.9 times (p < 0.001) greater than that in the control pathology group (see Table 3). After 72 h, the content of Rt in the animals which received magnetite NPs, also exceeded the control level significantly (p < 0.002).

The presence of protective effect within 3 h after the administration of aqueous dispersion of magnetite NPs may show that these non-stabilized NPs are rapidly distributed in the body, captured by the cells of reticuloendothelial system and included into erythropoiesis. This does not contradict the known data on the pharmacokinetics of magnetite NPs of other origin [34, 49].

It should be noted that anti-anemic effect of the single dose of investigated magnetite NPs persists even in the last observation period when hematological parameters are higher than the analogous ones for the blood loss without pharmacological correction. In this case, more intensive increase in the content of Rt evidently supports the fact that used magnetite NPs provide the restoration of key parameters of “red” blood precisely due to the activation of erythron regenerative reaction.

This means that even without stabilization magnetite NPs deposited in the porous matrix of NaCl and used as ex tempore aqueous dispersion have a characteristic anti-anemic effect associated with biomedical application.

4 Conclusion

Physical synthesis of iron NPs from the vapor phase is possible using the EB-PVD method. With rapid recovery from vacuum, iron NPs are oxidized in the air to magnetite. In the initial state, they have considerable sorption capacity with respect to oxygen and moisture. When heated in the air to 650 °C, the mass of porous condensate decreases due to desorption of physically sorbed moisture. Physically adsorbed oxygen participates in the oxidation of Fe3O4 to Fe2O3 (380–650 °C). An increase in the condensation temperature is accompanied by the increase in NPs size resulting in the reduction of total surface area of the nanoparticles and their sorption capacity.

Magnetite NPs deposited in NaCl crystals by EB-PVD technology can be dispersed in the water and used to correct anemia caused by acute blood loss. In a dose of 6.75 mg Fe/kg, they produce protective effect on RBC, Hct and Hb and activate the regenerative response of the bone marrow of laboratory animals that is manifested by an increase in Rt content in the blood.

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Revia RA, Zhang M (2016) Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. MaterialsToday 19(3):157–168.  https://doi.org/10.1016/j.mattod.2015.08.022 CrossRefGoogle Scholar
  2. 2.
    Cabuil V (2008) Magnetic nanoparticles: In: Schwarz JA, Contescu CI, Putyera K (eds) Dekker encyclopedia of nanoscience and nanotechnology, vol 3. CRC Press, Taylor and Francis Group, Boca Raton, Fl, pp 1985–2000. https://www.amazon.com/Dekker-Encyclopedia-Nanoscience-Nanotechnology-3/dp/0824750497
  3. 3.
    Willard MA, Kurihara LK, Carpenter EE, Calvin S, Harris VG (2004) Chemically prepared magnetic nanoparticles. Int Mater Rev 49:125–170.  https://doi.org/10.1179/095066004225021882 CrossRefGoogle Scholar
  4. 4.
    Nikolaev VI, Shipilin AM, Zakharova IN (2001) On estimating nanoparticle size with the help of the Mössbauer effect. Phys Solid State 43:1515–1517.  https://doi.org/10.1134/1.1395093 CrossRefGoogle Scholar
  5. 5.
    Thach CV, Hai NH, Chau N (2008) Size controlled magnetite nanoparticles and their drug loading ability. J Kor Phys Soc 52:1332–1335.  https://doi.org/10.3938/jkps.52.1332 CrossRefGoogle Scholar
  6. 6.
    Shpak AP, Gorbyk PP (2009) Nanomaterials and supramolecular structures: physics, chemistry, and applications. Springer, Dordrecht, p 420. http://www.springer.com/gp/book/9789048123087
  7. 7.
    Yu J, Yang C, Li J, Ding Y, Zhang L, Yousaf MZ, Lin J, Pang R, Wei L, Xu L, Sheng F, Li C, Li G, Zhao L, Hou Y (2014) Multifunctional Fe5C2 nanoparticles: a targeted theranostic platform for magnetic resonance imaging and photoacoustic tomography-guided photothermal therapy. Adv Mater 26(24):4114–4120.  https://doi.org/10.1002/adma.201305811 CrossRefGoogle Scholar
  8. 8.
    Ju Y, Zhang H, Yu J, Tong S, Tian N, Wang Z, Wang X, Su X, Chu X, Lin J, Ding Y, Li G, Sheng F, Hou Y (2017) Monodisperse Au–Fe2C janus nanoparticles: an attractive multifunctional material for triple-modal imaging-guided tumor photothermal therapy. ACS Nano 11(9):9239–9248.  https://doi.org/10.1021/acsnano.7b04461 CrossRefGoogle Scholar
  9. 9.
    Kopanja L, Kralj S, Zunic D, Loncar B, Tadić M (2016) Core–shell superparamagnetic iron oxide nanoparticle (SPION) clusters: TEM micrograph analysis, particle design and shape analysis. Ceram Int 42:10976–10984.  https://doi.org/10.1016/j.ceramint.2016.03.235 CrossRefGoogle Scholar
  10. 10.
    Tadić M, Kralj S, Jagodic M, Hanzel D, Makovec D (2014) Magnetic properties of novel superparamagnetic iron oxide nanoclusters and their peculiarity under annealing treatment. Appl Surf Sci 322:255–264.  https://doi.org/10.1016/j.apsusc.2014.09.181 CrossRefGoogle Scholar
  11. 11.
    Wang X, Zhang P, Wang W, Lei X, Yang H (2016) Magnetic N-enriched Fe3C/graphitic carbon instead of Pt as an electrocatalyst for the oxygen reduction reaction. Chem Eur J 22:4863–4869.  https://doi.org/10.1002/chem.201505138 CrossRefGoogle Scholar
  12. 12.
    Elmore WC (1938) Ferromagnetic colloid for studying magnetic structures. Phys Rev 54:309–310.  https://doi.org/10.1103/PhysRev.54.309 CrossRefGoogle Scholar
  13. 13.
    Klabunde K, Sergeev GB (2013) Nanochemistry, 2nd edn. Elsevier, p 372. https://www.elsevier.com/books/nanochemistry/klabunde/978-0-444-59397-9
  14. 14.
    Cushing BL, Kolesnichenko VL, O′Connor CJ (2004) Recent advances in the liquid-phase syntheses of inorganic nanoparticles. Chem Rev 104:3893–3946.  https://doi.org/10.1021/cr030027b CrossRefGoogle Scholar
  15. 15.
    Burda C, Chen X, Narayanan R, El-Sayed MA (2005) Chemistry and properties of nanocrystals of different shapes. Chem Rev 105(4):1025–1102.  https://doi.org/10.1021/cr030063a CrossRefGoogle Scholar
  16. 16.
    Kopanja L, Milošević I, Panjan M, Damnjanovic V, Tadić M (2016) Sol–gel combustion synthesis, particle shape analysis and magnetic properties of hematite (α-Fe2O3) nanoparticles embedded in an amorphous silica matrix. Appl Surf Sci 362:380–386.  https://doi.org/10.1016/j.apsusc.2015.11.238 CrossRefGoogle Scholar
  17. 17.
    Tadić M, Kusigerski V, Marković D, Panjan M, Milošević I, Spasojević V (2012) Highly crystalline superparamagnetic iron oxide nanoparticles (SPION) in a silica matrix. J Alloys Compd 525:28–33.  https://doi.org/10.1016/j.jallcom.2012.02.056 CrossRefGoogle Scholar
  18. 18.
    Billas IML, Chatelain A, de Heer WA (1997) Magnetism of Fe, Co and Ni clusters in molecular beams. J Magn Magn Mater 168(1–2):64–84.  https://doi.org/10.1016/S0304-8853(96),00694-4 CrossRefGoogle Scholar
  19. 19.
    Billas IML, Chatelain A, de Heer WA (1996) Magnetism in transition-metal clusters from the atom to the bulk. Surf Rev Lett 3(1):429–434.  https://doi.org/10.1142/S0218625X96000772 CrossRefGoogle Scholar
  20. 20.
    Gubin SP, Koksharov YuA, Khomutov GB, Yurkov GYu (2005) Magnetic nanoparticles: preparation, structure and properties. Russ Chem Rev 74(6):489–520.  https://doi.org/10.1070/RC2005v074n06ABEH000897 CrossRefGoogle Scholar
  21. 21.
    Roca AG, Costo R, Rebolledo AF, Veintemillas-Verdauguer S, Tartaj P, Gonzales-Carrenno T et al (2009) Progress in the preparation of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 42(22):224002.  https://doi.org/10.1088/0022-3727/42/22/224002 CrossRefGoogle Scholar
  22. 22.
    Movchan BA, Kurapov YuA, Didikin GG, Litvin SG, Romanenko SM (2011) Control of the composition and structure of Fe-O nanoparticles during Fe3O4 electron beam evaporation. Powder Metall Met Ceram 50(3–4):167–172.  https://doi.org/10.1007/s11106-011-9314-0 CrossRefGoogle Scholar
  23. 23.
    Kurapov YuA, Krushinskaya LA, Litvin SE, Romanenko SM, Stelmakh YaA, Markiev VYa (2014) Production and thermal stability of silver nanoparticles in the Ag–O system. Powder Metall Met Ceram 53(3–4):199–204.  https://doi.org/10.1007/s11106-014-9604-4 CrossRefGoogle Scholar
  24. 24.
    Kurapov YuA, Litvin SE, Romanenko SM (2013) Structure and thermal stability of Ti–NaCl condensates deposited from the vapour phase in vacuum. Nanostruct Mater Sci (1):55–62. http://www.materials.kiev.ua/science/edition_view.jsp?id=2
  25. 25.
    Kurapov YuA, Litvin SE, Didikin GG, Romanenko SM (2011) Structure of two-phase Cu-NaCl condensates, deposited in vacuum from the vapour phase. Adv Electrometall 9(2):82–86. https://patonpublishinghouse.com/eng/journals/sem/2011/02/05
  26. 26.
    Kurapov YuA, Romanenko SM, Didikin GG, Oranskaya EI (2017) Controllable synthesis of iron oxide nanoparticles in porous NaCl matrix. Mater Res Express 4(3):035031.  https://doi.org/10.1088/2053-1591/4/3/035031 CrossRefGoogle Scholar
  27. 27.
    Kovinsky IS, Krushinskaya LA, Movchan BA (2011) Structure and some properties of sodium chloride condensates produced by electron beam evaporation with next deposition in vacuum. Adv Electrometall 9(1):42–46. https://patonpublishinghouse.com/eng/journals/sem/2011/01/08
  28. 28.
    Chekman IS, Ul’berh ZR, Malanchuk VO, Horchakova NO, Zupanets’ IA (2012) Nanoscience, nanobiology, nanofarmation, Kyiv, Polihraf plyus, 328. https://www.twirpx.com/file/1157774/
  29. 29.
    Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV et al (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6):2064–2110.  https://doi.org/10.1021/cr068445e CrossRefGoogle Scholar
  30. 30.
    Santhosh PB, Ulrih NP (2013) Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. Cancer Lett 336(1):8–17.  https://doi.org/10.1016/j.canlet.2013.04.032 CrossRefGoogle Scholar
  31. 31.
    Jin R, Lin B, Li D, Ai H (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27.  https://doi.org/10.1016/j.coph.2014.08.002 CrossRefGoogle Scholar
  32. 32.
    Wang YXJ (2011) Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imag Med Surg 1(1):35–40.  https://doi.org/10.3978/j.issn.2223-4292.2011.08.03 CrossRefGoogle Scholar
  33. 33.
    Rosner MH, Auerbach M (2011) Ferumoxytol for the treatment of iron deficiency. Expert Rev Hematol 4(4):399–406.  https://doi.org/10.1586/ehm.11.31 CrossRefGoogle Scholar
  34. 34.
    Roohi F, Lohrke J, Ide A, Schutz G, Dassler K (2012) Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles. Int J Nanomedicine 7:4447–4458.  https://doi.org/10.2147/IJN.S33120 CrossRefGoogle Scholar
  35. 35.
    Ni F, Jiang L, Yang R, Chen Z, Qi X, Wang J (2012) Effects of PEG length and iron oxide nanoparticles size on reduced protein adsorption and non-specific uptake by macrophage cells. J Nanosci Nanotechnol 12(3):2094–2100.  https://doi.org/10.1166/jnn.2012.5753 CrossRefGoogle Scholar
  36. 36.
    Briley-Saebo KC, Johansson LO, Hustvedt SO, Haldorsen AG, Bjørnerud A, Fayad ZA et al (2006) Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism. Invest Radiol 41(7):560–571.  https://doi.org/10.1097/01.rli.0000221321.90261.09 CrossRefGoogle Scholar
  37. 37.
    Paton BYe, Movchan BO, Kurapov YuA, Yakovchuk KYu (2010) Method of obtaining nanoparticles of metal-oxygen system with given composition by electron beam evaporation and condensation in vacuum, U.A. Pat. # 92556 from 10. 11. 2010, Bull. # 21/2010, http://base.ukrpatent.org/searchINV/search.php?action=viewdetails&IdClaim=151646
  38. 38.
    Lebedev AD, Levchuk YN, Lomakin AV, Noskin VA (1987) Laser correlation spectroscopy in biology, Kiev, Naukova Dumka, p 255. https://search.rsl.ru/ru/record/01001388286
  39. 39.
    Merkus HG (2009) Particle size measurements. Fundamentals, practice, quality. Springer, http://www.springer.com/gp/book/9781402090158
  40. 40.
    Доклінічні дослідження лікарських засобів: методичні рекомендації (2001)/наук. ред. Стефанов О.В. К.: Авіцена, p 528. https://www.twirpx.com/file/537410/
  41. 41.
    Антонов ВС, Богомолова НВ, Волков АС (2010) Автоматизация гематологического анализа. Справочник заведующего клинико-диагностической лабораторией; №1, http://www.mcfr.ru/journals/41/256/17837/21349
  42. 42.
    Камышников ВС, Волотовская ОА, Ходюкова АБ (2013) Методы клинических лабораторных исследований, под ред. проф. Камышникова ВС. 6-е изд. М.: МЕДпресс-информ, 736 p., http://www.med-press.ru/upload/iblock/7c7/7c74480a0c810516688f16c98f54ab0a.pdf
  43. 43.
    Мовчан БА, Демчишин АВ (1969) Исследование структуры и свойств толстых вакуумных конденсатов никеля, вольфрама, оксида алюминия и диоксида циркония, Физика металлов и металловедение 28(4):653–660, http://impo.imp.uran.ru/fmm/Electron/vol28_4/abstract10.pdf
  44. 44.
    Kaygorodov AS, Ivanov VV, Paranin SN, Nozdrin AA (2007) The role of adsorbats in pulsed compaction of oxide nanopowders. Nanotechnol Russ 2:112–118. http://pleiades.online/ru/journals/search/?name=nanotech
  45. 45.
    de Boer JH (1968) The dynamic character of adsorption. Oxford University Press, London, p 240. https://books.google.com.ua/books?id=e8N4AAAAIAAJ&hl=ru&source=gbs_book_other_versions
  46. 46.
    Leibnitz E, Struppe HG (1984) Handbuch der gaschromatographie, Akademishe Verlagsgesellschaft Geest & Porting K.-G., Leipzig, 828 s., http://onlinelibrary.wiley.com/doi/10.1002/food.19850290727/abstract
  47. 47.
    Nelson CT, Elam JW, Cameron MA, Tolbert MA (1998) George SM (1998) Desorption H2O from hydroxylated single-crystal α-Al2O3 (0001) surface. Surf Sci 416(3):341–353.  https://doi.org/10.1016/S0039-6028(98),00439-7 CrossRefGoogle Scholar
  48. 48.
    Lj Kundacovic, Mullins DR, Overbury SH (2000) Adsorption and reaction of H2O and CO on oxidized and reduced Rh/CeOx (111) surfaces. Surf Sci 457(1–2):51–62.  https://doi.org/10.1016/S0039-6028(00),00332-0 CrossRefGoogle Scholar
  49. 49.
    Lind K, Kresse M, Debus NP, Muller RH (2002) A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. J Drug Target 10(3):221–230.  https://doi.org/10.1080/10611860290022651 CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Yurii A. Kurapov
    • 1
  • Elena M. Vazhnichaya
    • 2
  • Stanislav E. Litvin
    • 1
    • 4
  • Sergey M. Romanenko
    • 1
  • Gennadii G. Didikin
    • 1
  • Tatiana A. Devyatkina
    • 2
  • Yevhen V. Mokliak
    • 2
  • Elena I. Oranskaya
    • 3
  1. 1.E. O. Paton Electric Welding Institute of the National Academy of Science of UkraineKyivUkraine
  2. 2.Higher State Educational Establishment of Ukraine “Ukrainian Medical Stomatological Academy”PoltavaUkraine
  3. 3.Chuiko Institute of Surface Chemistry of the National Academy of Science of UkraineKyivUkraine
  4. 4.KyivUkraine

Personalised recommendations